# New England Realty Associates Limited Partnership: financial statements, quarterly

NEN · NYSE · CIK 746514 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nen.md) · [Financials](/companies/nen/financials.md) · [Filings](/companies/nen/filings.md) · [Insiders](/companies/nen/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nen/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.2](/filings/0001558370-24-015004.md) | [19.7](/filings/0001558370-25-003015.md) | [0.2](/filings/0001558370-25-007180.md) | [0.2](/filings/0001558370-25-010910.md) | [0.2](/filings/0001104659-25-108441.md) | [20.4](/filings/0001104659-26-027586.md) | [0.2](/filings/0001104659-26-057710.md) | [0.2](/filings/0001104659-26-092533.md) | [0.2](/filings/0001104659-25-108441.md) | [23.6](/filings/0001104659-26-027586.md) | [0.2](/filings/0001104659-26-057710.md) | [0.2](/filings/0001104659-26-092533.md) |
| Operating income | $m | [4.9](/filings/0001558370-25-003015.md) | [4.7](/filings/0001558370-25-003015.md) | [5.8](/filings/0001104659-26-027586.md) | [6.5](/filings/0001104659-26-027586.md) | [6.5](/filings/0001104659-26-027586.md) | [6.6](/filings/0001104659-26-027586.md) | [6.2](/filings/0001104659-26-057710.md) | [7.1](/filings/0001104659-26-092533.md) | [4.7](/filings/0001104659-26-027586.md) | [3.3](/filings/0001104659-26-027586.md) | [1.5](/filings/0001104659-26-057710.md) | [4.0](/filings/0001104659-26-092533.md) |
| Interest expense | $m | [4.0](/filings/0001558370-23-018465.md) | [3.9 d](/filings/0001558370-24-003239.md) | [3.9](/filings/0001558370-24-007577.md) | [3.9](/filings/0001558370-25-010910.md) | [3.8](/filings/0001104659-25-108441.md) | [3.8 d](/filings/0001104659-26-027586.md) | [3.8](/filings/0001104659-26-057710.md) | [4.1](/filings/0001104659-26-092533.md) | [5.4](/filings/0001104659-25-108441.md) | [5.2 d](/filings/0001104659-26-027586.md) | [5.7](/filings/0001104659-26-057710.md) | [5.7](/filings/0001104659-26-092533.md) |
| Income tax | $m | [0.0 d](/filings/0001558370-23-018465.md) | [0.0 d](/filings/0001558370-24-003239.md) | [0.0](/filings/0001558370-24-007577.md) | [0.0 d](/filings/0001558370-24-011545.md) | [0.0 d](/filings/0001558370-24-015004.md) | [0.0 d](/filings/0001558370-25-003015.md) | [0.0](/filings/0001558370-25-007180.md) | [0.0 d](/filings/0001558370-25-010910.md) | [0.0 d](/filings/0001104659-25-108441.md) | not reported | [0.0](/filings/0001104659-26-057710.md) | [0.0 d](/filings/0001104659-26-092533.md) |
| Net income | $m | [2.2](/filings/0001558370-25-003015.md) | [2.3](/filings/0001558370-25-003015.md) | [3.5](/filings/0001104659-26-027586.md) | [4.1](/filings/0001104659-26-027586.md) | [3.9](/filings/0001104659-26-027586.md) | [4.2](/filings/0001104659-26-027586.md) | [3.8](/filings/0001104659-26-057710.md) | [4.1](/filings/0001104659-26-092533.md) | [(0.5)](/filings/0001104659-26-027586.md) | [(1.4)](/filings/0001104659-26-027586.md) | [(3.9)](/filings/0001104659-26-057710.md) | [(1.2)](/filings/0001104659-26-092533.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.1](/filings/0001558370-23-018465.md) | [18.2](/filings/0001558370-25-003015.md) | [28.8](/filings/0001558370-24-007577.md) | [13.5](/filings/0001558370-24-011545.md) | [15.1](/filings/0001558370-24-015004.md) | [17.6](/filings/0001104659-26-027586.md) | [30.9](/filings/0001558370-25-007180.md) | [16.7](/filings/0001558370-25-010910.md) | [13.4](/filings/0001104659-25-108441.md) | [26.7](/filings/0001104659-26-092533.md) | [25.6](/filings/0001104659-26-057710.md) | [24.7](/filings/0001104659-26-092533.md) |
| Total assets | $m | [386](/filings/0001558370-23-018465.md) | [386](/filings/0001558370-25-003015.md) | [381](/filings/0001558370-24-007577.md) | [384](/filings/0001558370-24-011545.md) | [387](/filings/0001558370-24-015004.md) | [394](/filings/0001104659-26-027586.md) | [385](/filings/0001558370-25-007180.md) | [495](/filings/0001558370-25-010910.md) | [493](/filings/0001104659-25-108441.md) | [505](/filings/0001104659-26-092533.md) | [497](/filings/0001104659-26-057710.md) | [494](/filings/0001104659-26-092533.md) |
| Total liabilities | $m | [451](/filings/0001558370-23-018465.md) | [451](/filings/0001558370-25-003015.md) | [450](/filings/0001558370-24-007577.md) | [451](/filings/0001558370-24-011545.md) | [453](/filings/0001558370-24-015004.md) | [456](/filings/0001104659-26-027586.md) | [457](/filings/0001558370-25-007180.md) | [564](/filings/0001558370-25-010910.md) | [564](/filings/0001104659-25-108441.md) | [580](/filings/0001104659-26-092533.md) | [577](/filings/0001104659-26-057710.md) | [577](/filings/0001104659-26-092533.md) |
| Long-term debt | $m | [412](/filings/0001558370-23-018465.md) | [411](/filings/0001558370-24-003239.md) | [411](/filings/0001558370-24-007577.md) | [410](/filings/0001558370-24-011545.md) | [409](/filings/0001558370-24-015004.md) | [409](/filings/0001558370-25-003015.md) | [408](/filings/0001558370-25-007180.md) | [514](/filings/0001558370-25-010910.md) | [514](/filings/0001104659-25-108441.md) | [531](/filings/0001104659-26-027586.md) | [530](/filings/0001104659-26-057710.md) | [529](/filings/0001104659-26-092533.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.7 d](/filings/0001558370-24-015004.md) | [11.0 d](/filings/0001104659-26-027586.md) | [6.1](/filings/0001558370-25-007180.md) | [5.4 d](/filings/0001558370-25-010910.md) | [8.5 d](/filings/0001104659-25-108441.md) | [12.0 d](/filings/0001104659-26-027586.md) | [5.5](/filings/0001104659-26-057710.md) | [12.5 d](/filings/0001104659-26-092533.md) | [2.3 d](/filings/0001104659-25-108441.md) | [7.3 d](/filings/0001104659-26-027586.md) | [2.3](/filings/0001104659-26-057710.md) | [5.3 d](/filings/0001104659-26-092533.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 3,108,860 at 2013-11-13, from the cover of the [10-Q filed 2013-11-14](/filings/0001104659-13-084544.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.